# K051969: Tricat Ria (Adrenalin/Noradrenalin/Dopamine); Katcombi Ria (Adrenalin/Noradrenalin); Noradrenalin Ria

- Pathway: 510(k) (Traditional)
- Applicant: Ibl GmbH
- Decided: Oct 3, 2005 after 75 days
- Product code: CHQ (Chromatographic/Fluorometric Method, Catecholamines)
- Device class: 1
- Regulation: 21 CFR 862.1165
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
No later device cites it as a predicate yet.
0 of 1 device in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. FDA’s file for it is a 510(k) statement, which names no predicate.

## Indications for use
The IBL Catecholamine RIA test kits are for the in-vitro-diagnostic quantitative determination and/or of the catecholamines adrenaline (epinephrine), noradrenaline (norepinephrine) dopamine (either separate or combined) in human plasma and urine. The Catecholamine test kits are useful as an aid in the diagnosis as well as the follow-up of the tumor diseases of the nervous system, especially of the pheochromocytoma, but also neuroblastoma and the ganglioneuroma.

Source page: https://510kreport.com/device/K051969
Methodology: https://510kreport.com/methodology